ATORVASTATIN CALCIUM | N213260 | CMP DEVELOPMENT LLC
1 strength6 unique patents0 unique exclusivities
Products (1)
Patents (6)
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|
| 11369567 | Jun 7, 2037 | — | — | Yes | — | — |
| 11654106 | Jun 7, 2037 | — | — | Yes | | — |
| 11925704 | Jun 7, 2037 | — | — | Yes | | — |
| 12168069 | Jun 7, 2037 | — | — | Yes | — | — |
| 12370136 | Jun 7, 2037 | — | — | Yes | — | — |
| 12599553 | Jun 7, 2037 | — | — | Yes | — | — |
ADDED7/1/2026
Atorvastatin calcium (Atorvaliq) received a new patent listing (U.S. Patent 12,599,553) in the Orange Book for NDA 213260.